IOBT
IO Biotech
IOBT
IOBT
Delisted
IOBT was delisted on the 6th of April, 2026.
21 hedge funds and large institutions have $3.59M invested in IO Biotech in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
86% less capital invested
Capital invested by funds: $25.3M → $3.59M (-$21.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.63M | |
| 2 | +$2.4M | |
| 3 | +$1.02M | |
| 4 |
Renaissance Technologies
New York
|
+$703K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$431K |
Top Sellers
| 1 | -$8.58M | |
| 2 | -$2.74M | |
| 3 | -$1.81M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$1.45M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.41M |